Instructions for
Authors
ONLINE MANUSCRIPT SUBMISSION: An online submission
and tracking service via Internet facilitates a speedy
and cost-effective submission of manuscripts. The full manuscript
has to be submitted online via Bentham's Content
Management System (CMS) at http://bsp-cms.eurekaselect.com/index.php/IAD/
(View Submission
Instructions). Alternatively, you may submit
the full paper to patents@benthamscience.org
Manuscripts must be submitted by one of the authors of the
manuscript, and should not be submitted by anyone on their
behalf. The principal/corresponding author will be required
to submit a Cover Letter along with the manuscript, on behalf
of all the co-authors (if any) to confirm that the manuscript
(or any part of it) has not been published previously or is
not under consideration for publication elsewhere. Furthermore,
any illustration, structure or table that has been published
elsewhere must be reported, and copyright permission for reproduction
must be obtained. The figures from patent documents are freely
available on the databases and may not require any permission
unless stated otherwise.
For all online submissions, please provide soft copies of
all the materials (main text in MS Word or Tex/LaTeX), figures/illustrations
in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw
(CDX)/ISISDraw (TGF) as separate files, while a PDF version
of the entire manuscript must also be included, embedded with
all the figures/illustrations/tables/chemical structures etc.
It is advisable that the document files related to a manuscript
submission should always have the name of the corresponding
author as part of the file name, i.e., “Cilli MS text.doc”,
“Cilli MS Figure 1”, etc.
It is imperative that before submission, the author(s)
should carefully proofread the files for special characters,
mathematical symbols, Greek letters, equations, tables, references
and images to ensure that they appear in proper format.
References, figures, tables, chemical structures,
etc. should be referred to in the text at the appropriate
places where they have been first discussed. Figure legends/captions
should also be provided.
A successful electronic submission of the manuscript will
be confirmed by a system-generated email acknowledgement to
the principal/corresponding author immediately. Any queries
therein should be addressed to patents@benthamscience.org
MANUSCRIPTS PUBLISHED: The journal
publishes peer-reviewed mini- and full-length review and research
articles written in English. Single Topic/Thematic Issues
edited by invited Guest Editors are also considered for publication.
For the submission of research articles, the author should
have already filed a patent with a leading patent authority
and it should be registered. Secondly, the author should not
have published any research paper on the intellectual property
of that patent.
Single Topic Issues: These special issues
are peer-reviewed and may contain invited or uninvited review/mini-review
articles or a mixture of research articles and reviews/ mini-reviews.
A Single Topic Issue Editor will offer a short perspective
and co-ordinate the solicitation of manuscripts between 3-5
(for a mini-hot topic) to 6-10 (for full-length hot topic)
from leading scientists. Authors interested in editing a single
topic issue in an emerging topic of inflammation & allergy
drug discovery may submit their proposal to the Executive
Editor at patents@benthamscience.org
or iad@benthamscience.org
for consideration.
Patent Selections: A
separate section of important and recent patents on inflammation
& allergy drug discovery is also included in the journal.
The patents annotated in this section are relevant to the
articles published in this journal issue, categorized by therapeutic
areas/targets and therapeutic agents related to inflammation
& allergy drug discovery.
MANUSCRIPT LENGTH:
Research Articles: Research articles should
be 4000-8000 words excluding figures, structures, photographs,
schemes, tables etc.
Mini-Reviews: Mini-reviews should be 3000-6000
words excluding figures, structures, photographs, schemes,
tables etc.
Full-Length Reviews: Full-length reviews
should be 8000-40000 words excluding figures, structures,
photographs, schemes, tables etc.
There is no restriction on the number of figures, tables or
additional files e.g. video clips, animation and datasets,
that can be included with each article online. Authors should
include all relevant supporting data with each article (Refer
to Supplementary Material section).
MANUSCRIPT PREPARATION: The manuscript should
be written in English in a clear, direct and active style.
All pages must be numbered sequentially, facilitating in the
reviewing and editing of the manuscript. For further convenience,
our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS:
Manuscripts may be divided into the following sections:
1. Cover Letter: It is mandatory to submit
a signed covering letter along with the manuscript, by the
author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
should not contain any material or information that may be
unlawful, defamatory, fabricated, plagiarized, or which would,
if published, in any way whatsoever, violate the terms and
conditions as laid down in the copyright agreement. The authors
should acknowledge that the publishers have the legal right
to take appropriate action against the authors for any such
violation of the terms and conditions as laid down in the
copyright agreement. To download the cover letter, please
visit: www.benthamscience.com/iad/Covering-Letter.pdf
2. Title: The title of the article should
be precise and brief and must not be more than 120 characters.
Authors should avoid the use of non-standard abbreviations.
The title must be written in title case except for articles,
conjunctions and prepositions.
3. Short Running Title: Authors must provide
a short ‘running title’ of their manuscripts.
4. Authors’ Names and Affiliations:
The names of the authors should be provided according to the
previous citations or as the authors would want them to be
published along with the institutional affiliations, current
address, telephone, cell & fax numbers and the email address.
Email address must be provided with an asterisk in front of
the name of the principal author. The corresponding author
should also be designated and the full address, telephone,
cell & fax numbers and the email address must be stated
to receive correspondence and galley proofs.
5. Abstract: The abstract summarizing the
essential features of the review or research article should
not exceed 200 words and must include information regarding
patents.
6. Keywords: Authors must provide 6 to 8
keywords in alphabetical order.
7. Text Organization: The main text should
begin on a separate page and should be divided into title
page, abstract and the main text. The text may be subdivided
further according to the areas to be discussed, which should
be followed by the Acknowledgement (if any) and Reference
sections. The Review Article should mention any previous important,
recent and old reviews in the field and contain a comprehensive
discussion starting with the general background of the field.
It should then go on to discuss the salient features of recent
developments along with relevant patents. The authors should
avoid presenting material which has already been published
in a previous review. The authors are advised to present and
discuss their observations in brief. For Research Articles,
the manuscript should begin with the title page and abstract
followed by the main text, which must be structured into separate
sections as Introduction, Material and Methods, Results,
Discussion, Conclusion, Current & Future Developments,
Acknowledgements, Conflict of Interest and References.
The patent registration number and patent authority of the
author's intellectual property must be cited in the article.
The manuscript style must be uniform throughout the text and
10pt Times New Roman font should be used. The full term for
an abbreviation should precede its first appearance in the
text unless it is a standard unit of measurement. Italics
should be used for Binomial names of organisms (Genus and
Species) for emphasis and for unfamiliar words or phrases.
Non-assimilated words from Latin or other languages should
also be italicized e.g. per se, et al., in vitro, in vivo,
in situ, etc.
Standard Protocol on Approvals, Registrations, Patient
Consents & Animal Protection: All clinical investigations
must be conducted according to the Declaration of Helsinki
principles. Authors must comply with the guidelines of the
International Committee of Medical Journal Editors (http://www.icmje.org)
with regard to the patient’s consent for research or
participation in a study. Patients' names, initials, or hospital
numbers must not be mentioned anywhere in the manuscript (including
figures). Editors may request that authors provide documentation
of the formal review and recommendation from the institutional
review board or ethics committee responsible for oversight
of the study.
In addition to the standard patient consent for participation
in research, authors are responsible for obtaining patient
consent-to-disclose forms for all recognizable patients in
photographs, videos, or other information that may be published
in the Journal, in derivative works, or on the journal’s
web site and providing the manuscript to the recognizable
patient for review before submission. The consent-to-disclose
form should indicate specific use (publication in the medical
literature in print and online, with the understanding that
patients and the public will have access) of the patient's
information and any images in figures or videos, and must
contain the patient's signature or that of a legal guardian
along with a statement that the patient or legal guardian
has been offered the opportunity to review the identifying
materials and the accompanying manuscript.
For research involving animals, the authors should indicate
whether the procedures followed were in accordance with the
standards set forth in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Science, National
Academy Press, Washington, D.C.).
A specific declaration of such approval and consent-to-disclose
form must be made in the cover letter and in a stand-alone
paragraph at the end of the Methods section especially in
the case of human studies where inclusion of a statement regarding
obtaining the written informed consent from each subject or
subject's guardian is a must. The original should be retained
by the guarantor or corresponding author. Editors may request
to provide the original forms by fax or email.
Patent Review Coverage: Authors
should review the most recent and important patents based
on the topic covered. Coverage of novel bioactive compounds,
analogs & targets, techniques and drug design in all areas
of inflammation & allergy drug discovery should be emphasized,
including the significance of reported patents.
Current & Future Developments:
The review/research article should conclude with a short section
called “Current & Future Developments”. The
author(s) will give their opinion on the current and future
important developments on the topic discussed in their article.
Symbols and Units: Greek symbols
and special characters often undergo formatting changes and
get corrupted or lost during preparation of a manuscript for
publication. To ensure that all special characters used are
embedded in the text, these special characters should be inserted
as a symbol but should not be a result of any format styling
(Symbol font face) otherwise they will be lost during the
conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design.
Only ISO symbols, written in italic, should be used for the
various parameters. All kinds of measurements should be reported
only in International System of Units (SI). SI units should
always be written in Roman and separated from the numerical
value by a space (whatever the language).
The µ in µg or µm should be in Roman. The
symbol for litre is L and that for minute is min. For temperature,
please use only one of °C, °F or K in the entire manuscript.
As the Angström (1Å = 10-10
m) is not an SI unit, it should be replaced by the nanometre
(1nm = 10-9 m) or by the
picometer (1pm = 10-12 m):
1Å = 0.1nm = 100 pm. Multiple units should be written
with negative superscripts (for example, 25mgµL-1
µs-1). The list of
notations should appear just before the first paragraph of
full text.
A list of symbols and units should be provided if used extensively
throughout the text.
8. List of Abbreviations: If abbreviations
are used in the text either they should be defined in the
text where first used, or a list of abbreviations can be provided.
9. Acknowledgements: The specific requirements
for authorship have been defined by the International Committee
of Medical Journal Editors (ICMJE; http://www.icmje.org).
Examples of authors' contributions are: 'designed research/study',
'performed research/study', 'contributed important reagents',
'collected data', 'analyzed data', 'wrote paper' etc.
This information must be included in the submitted manuscript
as a separate paragraph under the heading ‘Acknowledgements’.
The corresponding author is responsible for obtaining permission
from all co-authors for the submission of any version of the
manuscript and for any changes in the authorship.
All individuals listed as authors must have contributed substantially
to the design, performance, analysis, or reporting of the
work and are required to indicate their specific contribution.
Anyone (individual/company/institution) who has substantially
contributed to the study for important intellectual content,
or who was involved in the article’s drafting the manuscript
or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g.
research supervisor, departmental head) is discouraged.
10. Conflict of Interest: Financial contributions
to the work being reported must be clearly acknowledged, as
should any potential conflict of interest under the heading
‘Conflict of Interest’. Authors
must list the source(s) of funding for the study, for each
author, and for the manuscript preparation. No patents should
be cited by authors that are in various stages of legal litigation.
11. References: References should be numbered
sequentially [in square brackets] in the text and listed in
the same numerical order in the reference section. All references
must be complete and accurate. Online citations should include
the date of access. Journal titles should conform to the present
Index Medicus abbreviations. It is necessary to list all authors
if the total number of authors is 6 or less and for more than
6 authors use 6 authors and then et al. The reference
numbers must be finalized and the bibliography must be fully
formatted before submission.
References should be listed in the following Vancouver Style:
Journal:
[1] Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka
SR, et al. Association of a common vitamin D-binding protein
polymorphism with inflammatory bowel disease. Pharmacogenet
Genomics 2011;21(9):559-64.
Book:
[2] Monnier P. Pediatric Airway Surgery.
1st ed. Springer: New York
2011.
Book Chapter:
[3] Zur KB. The Critical Airway. In : Mattei P, Eds. Fundamentals
of Pediatric Surgery. New York: Springer 2011; 177-184.
Conference Proceedings:
[4] Moran GW, Leslie F, McLaughlin
JT. Gut hormones and appetite dysregulation in Crohn's disease.
The Proceedings of the Nutrition Society, Malnutrition
Matters, Joint BAPEN and Nutrition Society Meeting, Harrogate,
UK, November 2-3.
Meeting Abstract:
[5] Silverberg J, Durkin H, Joks
R. Correlates with Their Serum IgE Levels, and Phosphorylated
ERK Correlates with IgG Inhibition of Phosphorylated p38 MAPK
Expression by T Cells is Associated with Suppression of IgE
Responses. 11th Annual
Meeting of Federation of Clinical Immunology Societies.
Washington, USA (2011).
Website:
[6] Guidelines for the Diagnosis
and Management of Asthma (EPR-3) . Available at: http://www.nhlbi.nih.gov/guidelines/asthma/
(Accessed on: October 12, 2011).
Thesis:
[7] Moran GW. Enteroendocrine peptides
in intestinal inflammation. PhD Thesis, The University of
Manchester, June 2011.
Patent:
[8] As a service, the Publishers can provide each author a
certain number of relevant patents to assist them in writing
their article. All patent application references will be provided
by the author and will be published as it is.
Patent Reference Style: All
inventors' names of the cited patents must be stated with
the title, publication number and the year of publication
e.g. Shailubhai, K. Agonists of guanylate cyclase
useful for the treatment of gastrointestinal disorders, inflammation,
cancer and other disorders. US8034782 (2011).
Citation of the patents will be according to the international
convention as follows:
•WO patents: 1978-2003
Ponikau, J. Methods and materials for treating and preventing
inflammation of mucosal tissue. WO9920261 (1999).
Ashley, R. A. Methods of treating allergic reactions. WO03099270
(2003).
•WO patents: 2004 onwards
Schultz, J.R., Turner, C. Methods of treating inflammation.
WO2011116245 (2011).
•US Patent Applications: 2001 onwards
Levin, B.H. Compositions, kits, apparatus, and methods for
inhibiting cephalic inflammation. US20010004644 (2001).
Arad, Y., Dong, L.C. Controlled release of N-acetylcysteine
(NAC) for reduction of systemic and/or vascular inflammation.
US20110244045 (2011).
•Issued Patents:
Chiou, G.C.Y. Use of OB-101 to treat inflammation. US5344829
(1994).
Klimko, P.G., Beauregard, C. Method of treating ocular allergy.
US8034839 (2011)..
•EP patents:
Garman, A.J., Wheeler, A. Allergens modified with polysarcosines.
EP0038154 (1983).
Koga, Y., Shibata, R., Aiba, Y., Fukumori, Y., Takeda, H.
1-Kestose for treating allergy and atopic dermatitis. EP1878738
(2011).
Some important points to remember:
•Superscripts in the in-text citations and reference
section should be avoided.
•Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
•The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
12. Tables:
•Data tables should be submitted in Microsoft Word table
format.
•Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
•Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
•Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
•Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
•Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
•If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
•Tabular data provided as additional files can be submitted
as an MS Excel spreadsheet.
13. Figures/Illustrations: The quality of the illustrations
printed in the journal largely depends on the quality of the
figures/illustration provided by the author. The acceptance
of a manuscript for publication is subject to the figures
being up to the highest standards in terms of clarity and
resolution. In case, the figures supplied are not up to the
standards required, the authors will be given the option to
either return the manuscripts within one week with appropriate
drawings/figures or they may opt to have these professionally
prepared through the paid professional service available from
Bentham Publishing Services.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution:
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with color mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally a continuous tone photograph and contains no text, the preferred file format is TIFF, with color mode being RGB or Grayscale, in a resolution of 300 dpi.
For Combination image type, which is generally an image containing halftone in addition to text or line art elements, the preferred file format is TIFF, with color mode being or RGB or Grayscale, in a resolution of 500-900 dpi.
Formats:
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for diagrams)
• PNG (preferred format for photos or images)
• Microsoft Word (version 5 and above; figures must
be a single page)
• PowerPoint (figures must be a single page)
• TIFF
• JPEG (conversion should be done using the original
file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process figures submitted
in GIF format.
If the large size of TIFF or EPS figures acts as an obstacle to online submission, authors may find that conversion to JPEG format before submission results in significantly reduced file size and upload time, while retaining acceptable quality. JPEG is a 'lossy' format. However, in order to maintain acceptable image quality, it is recommended that JPEG files are saved at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include
GraphicConverter on the Macintosh, PaintShop Pro, for Windows,
and ImageMagick, which is available on Macintosh, Windows
and UNIX platforms.
Note that bitmap images (e.g. screenshots)
should not be converted to EPS, since this will result in
a much larger file size than the equivalent JPEG, TIFF, PNG
or BMP, with no increase in quality. EPS should only be used
for images produced by vector-drawing applications such as
Adobe Illustrator or CorelDraw. Most vector-drawing applications
can be saved in, or exported as, EPS format. In case the images
have been originally prepared in an Office application, such
as MS Word or PowerPoint, then the original MS Office files
should be directly uploaded to the site, instead of being
converted to JPEG or another format that may be of low quality.
Color Figures / Illustrations:
•The cost for the first published page of color figures is US$ 965; the second additional page will be for US$ 705 and each subsequent page for US$480.
•Color figures should be supplied in CMYK not RGB colors.
Chemical Structures:
Chemical structures must be prepared in ChemDraw (CDX)
and provided as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width
2.0 pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text Settings:
Font
Times New
Roman
Size
8 pt
Under the Preference Choose:
Units
points
Tolerances 3
pixels
Under Page Setup Use:
Paper
US letter
Scale
100%
14. Supportive/Supplementary Material: We
do encourage to append supportive material, for example a
PowerPoint file containing a talk about the study, a PowerPoint
file containing additional screenshots, a MS Word, RTF, or
PDF document showing the original instrument(s) used, a video,
or the original data (SAS/SPSS files, MS Excel files, Access
Db files etc.) provided it is inevitable or endorsed
by the journal's Editor.
Supportive/Supplementary Material intended for publication
must be numbered and referred to in the manuscript but
should not be a part of the submitted paper. In-text
citations as well as a section with the heading "Supportive/Supplementary
Material" before the "References" section should
be provided. Here, list all Supportive/Supplementary Material
and include a brief caption line for each file describing
its contents.
Any additional files will be linked into the final published
article in the form supplied by the author, but will not be
displayed within the paper. They will be made available in
exactly the same form as originally provided only
on our website. Please also make sure that each additional
file is a single table, figure or movie (please do not upload
linked worksheets or PDF files larger than one sheet). Supportive/Supplementary
material must be provided in a single zipped file not larger
than 4 MB.
Authors must clearly indicate if these files are not for publication
but meant for the reviewers'/editors' perusal only.
PERMISSION FOR REPRODUCTION: Published/reproduced
material should not be included unless you have obtained written
permission from the copyright holder, which should be forwarded
to the Editorial Office in case of acceptance of your article
for publication.
For obtaining permission of reproducing any material published
in an article by Bentham Science Publishers,
please fill in the request FORM
and send to patents@benthamscience.org
for consideration.
REVIEWING AND PROMPTNESS OF PUBLICATION: All papers
submitted for publication are immediately subjected to editorial
scrutiny, usually in consultation with members of the journal
Editorial Advisory Board and outside independent reviewers.
Every effort will be made to peer review submitted papers
quickly. Papers which are delayed by authors in revision for
more than 30 days will have to be re-submitted as a new submission.
Papers accepted for publication are typeset and proofs are
dispatched to authors for any corrections prior to final publication.
PAGE CHARGES: No page charges will be levied to the
authors.
LANGUAGE AND EDITING: Manuscripts containing
many English typographical errors will not be published. Manuscripts
which are accepted for publication on condition that the written
English submitted is corrected will be sent a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries, who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
PROOFS: Authors will receive page proofs of their
accepted paper before publications. To avoid delays in publication,
proofs should be checked immediately for typographical errors
and returned within 48 hours. Major changes are not
acceptable at the proof stage. If unable to send corrections
within 48 hours due to some reason, the author(s) must
at least send an acknowledgement on receiving the galley proofs
or the article will be published exactly as received and the
publishers will not be responsible for any error occurring
in the published manuscript in this regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named (corresponding)
author will receive electronically five free eprints of their
published article. Printed reprints may be ordered from the
Publisher prior to publication of the article. First named
authors may also order a personal print and online subscription
of the journal at 50% off the normal subscription rate by
contacting the subscription department at e-mail: subscriptions@benthamscience.org
OPEN ACCESS PLUS: Accepted articles
can be published online for free open access for all to view,
and be deposited by the Publishers in PubMed Central. Open
access publishing provides the maximum dissemination of the
article to the largest audience. Authors must pay for this
service. All corresponding authors will be asked to indicate
whether or not they wish to pay to have their paper made freely
available on publication. If authors do not select the Open
Access option, then their article will be published with standard
subscription-based access at no charge.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 2,200 per
published article which allows indefinite free-to-view online
publication with Bentham Science.
For more information please contact us at e-mail: openaccess@benthamscience.org
COPYRIGHT: Authors who publish in Bentham
Science Journals will transfer copyright to their work
to Bentham Science Publishers. Submission
of a manuscript to the respective journals implies that all
authors have read and agreed to the content of the Covering
Letter or the Terms and Conditions. It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism or fabricated information is discovered. By
submitting a manuscript the authors agree that the copyright
of their article is transferred to the publishers if and when
the article is accepted for publication. Once submitted to
the journal, the author will not withdraw their manuscript
at any stage prior to publication.
Plagiarism Prevention: Bentham
Science Publisher uses the iThenticate software
to detect instances of overlapping and similar text in submitted
manuscripts. iThenticate software checks content uploaded
by a journal editorial office against a database of periodicals,
the Internet, and a comprehensive article database. It generates
a similarity report, including the percentage overlap between
the uploaded article and published material. Any instances
of content overlap are treated according to a journal’s
peer review integrity statement and the policies recommended
by the editorial Committee. You are assured that the publisher,
where you are submitting your manuscript, is committed to
actively combating plagiarism and publishing original research.
E-PUB AHEAD OF SCHEDULE:
Bentham Science Publishers are pleased
to offer electronic publication of accepted papers prior to
scheduled publication. These peer-reviewed papers can be cited
using the date of access and the unique DOI number. Any final
changes in manuscripts will be made at the time of print publication
and will be reflected in the final electronic version of the
issue. Articles ahead of schedule may be ordered by pay-per-view
at the relevant links by each article stated via
the E-Pub Ahead of Schedule (http://www.benthamscience.com/iad/E-Pub-Ahead-of-Schedule.htm).
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers,
the editors and authors and their respective employees are
not responsible or liable for the use of any such inaccurate
or misleading data, opinion or information contained of articles
in the E-Pub Ahead-of-Schedule.
|
